Brief: Hydration Pharmaceuticals Co Posts FY Loss After Tax Attributable $8.1 Mln
29/02/2024 01:36
Feb 29 (Reuters) - Hydration Pharmaceuticals Co Ltd
HPC.AX :
* FY LOSS AFTER TAX ATTRIBUTABLE $8.1 MILLION
* FY REVENUE UP 10% TO $10.0 MILLION
Further company coverage: HPC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hydration Pharmaceuticals
See all newsBrief: Hydration Pharmaceuticals Launches Pro Rata Entitlement Offer To Raise Up To A$1.43 MLN
Australia's Hydration Pharmaceuticals soars on upbeat monthly sales
Australia's Hydration Pharmaceuticals soars 144% on asset sale to US co
Brief: Hydration Pharmaceuticals Announces Divesture Of Hydralyte's Non-US Assets
Brief: Hydration Pharmaceuticals Says Adem Karafili Appointed Non-Executive Chairman